News

19Feb, 2019

CIRCULOGENE Names Anthony L. Schmidt, M.D., as Medical Director

CIRCULOGENE Names Anthony L. Schmidt, M.D., as Medical Director BIRMINGHAM, Ala. – CIRCULOGENE, advancing precision medicine through molecular genetics testing, has named Anthony L. Schmidt, M.D., F.A.C.P., as Medical Director. Dr. Schmidt will lead the [...]

13Feb, 2019

CIRCULOGENE Molecular Diagnostics Laboratory Receives College of American Pathologists (CAP) Accreditation

 BIRMINGHAM, Ala. – CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, announced today that its molecular diagnostics laboratory has received College of American Pathologists (CAP) accreditation based on a recent on-site inspection as part [...]

3Jan, 2019

CIRCULOGENE Expands Molecular Diagnostics Testing Footprint To Asia-Pacific Region

DATE: January 3, 2019 CIRCULOGENE Expands Molecular Diagnostics Testing Footprint To Asia-Pacific Region Strategic partnership broadens cancer-targeted molecular diagnostics and immunotherapy testing to rapidly growing Asia-Pacific market. BIRMINGHAM, Ala.– CIRCULOGENE, advancing precision medicine through molecular genetics [...]